D'ANNA, STEFANO
D'ANNA, STEFANO
Dipartimento di Biologia
Chronic HDV infection is sustained by an intense HBsAg production fromintegrated HBVDNA in the setting of a limited or even absent HBV reservoir.
2024-01-01 Salpini, 1r; D'Anna, S; Piermatteo, L; Brancaccio, G; Teti, E; Di Lorenzo, A; Grossi, I; Torre, G; Malagnino, V; Iannetta, M; Ceccherini-Silberstein, F; Pasquazzi, C; Cillo, U; Vitale, A; Gringeri, E; Magrofuoco, M; Pacenti, M; Baiocchi, L; Francioso, S; Lenci, I; Koffas, A; Geretti, A; Abate, Ml; Olivero, A; Gaeta, G; Sarmati, L; Rizzetto, M; Gill, U; Kennedy, P; Caviglia, Gp; Svicher., V
Comprehensive insight of epidemiological and virological features underlying patients with HBV/HDV co-infection drug-naïve or treated with the recently approved entry inhibitor
2023-01-01 D'Anna, S
Determinants of worse liver-related outcome according to HDV infection among HBsAg positive persons living with HIV: Data from the ICONA cohort
2024-02-01 d'Arminio Monforte, A; Tavelli, A; Salpini, R; Piermatteo, L; D'Anna, S; Carrara, S; Malagnino, V; Mazzotta, V; Brancaccio, G; Marchetti, Gc; Rosselli Del Turco, E; Rossotti, R; Mussini, C; Antinori, A; Lo Caputo, S; Ceccherini Silberstein, F; Gaeta, Gb; Svicher, V; Puoti, M
Different diagnostic performances of HDV RNA quantification assays used in clinical practicein Italy: results from a national quality control multicenter study.
2024-01-01 Salpini, 7r; Piermatteo, L; Caviglia, Gp; Bertoli, A; Brunetto, Mr; Bruzzone, B; Callegaro, A; Caudai, C; Cavallone, D; Chessa, L; Coghe, F; Coppola, N; Cuomo, N; D'Anna, S; Di Stefano, M; Duca, L; Facchetti, F; Farina, C; Ferraro, D; Franchin, E; Francisci, D; Galli, S; Garbuglia, Ar; Gennari, W; Ghisetti, V; Lampertico, P; Marascio, N; Menzo, S; Micheli, V; Niro, G; Olivero, A; Paba, P; Palermo, Ci; Palmieri, O; Paolucci, S; Pisaturo, M; Pollicino, T; Raffa, G; Torre, G; Turriziani, O; Uzzau, S; Vatteroni, M; Zazzi, M; Craxì, A; Ceccherini-Silberstein, F; Svicher On Behalf Of The Virology Italian Network Vironet C., V
Frequency of atypical mutations in the spike glycoprotein in SARS-CoV-2 circulating from July 2020 to July 2022 in central Italy: a refined analysis by Next Generation Sequencing
2023-01-01 Bellocchi, Mc; Scutari, R; Carioti, L; Iannetta, M; Marchegiani, G; Piermatteo, L; Coppola, L; Tedde, S; Duca, L; Malagnino, V; Ansaldo, L; Braccialarghe, N; D′Anna, S; Mercedes Santoro, M; DI LORENZO, A; Salpini, R; Teti, E; Svicher, V; Andreoni, M; Sarmati, L; Ceccherini-Silberstein, F
HBeAg Levels Vary across the Different Stages of HBV Infection According to the Extent of Immunological Pressure and Are Associated with Therapeutic Outcome in the Setting of Immunosuppression-Driven HBV Reactivation
2021-01-01 Piermatteo, L; Alkhatib, M; D’Anna, S; Malagnino, V; Bertoli, A; Andreassi, E; Basile, E; Iuvara, A; Maria De Cristofaro, ; Cappiello, G; Cerva, C; Minichini, C; Pisaturo, M; Starace, M; Coppola, N; Fontana, C; Grelli, S; Ceccherini-Silberstein, F; Andreoni, M; Gill, Us; Kennedy, Ptf; Sarmati, L; Salpini, R; Svicher, V
Hepatitis delta virus (HDV) infection : frequency and outcome in persons living with HIV (PLWH). Data from the ICONA (Italian cohort of naïve for antiretrovirals) cohort
2023-01-01 Puoti, M; Salpini, R; Tavelli, A; Piermatteo, L; D’Anna, S; Carrara, S; Malagnino, V; Mazzotta, V; Brancaccio, G; Battista Gaeta, G; Marchetti, G; Viale, P; Perno, C; Svicher, V; d’Arminio Monforte, A
Heterogeneity in the diagnostic performances of HDV RNA quantification assays used in clinical practice in Italy: results from a national quality control multicenter study.
2024-01-01 Salpini, 1r; Piermatteo, L; Caviglia, Gp; Bertoli, A; Brunetto, Mr; Bruzzone, B; Callegaro, A; Caudai, C; Cavallone, D; Chessa, L; Coghe, F; Coppola, N; Cuomo, N; D'Anna, S; Di Stefano, M; Duca, L; Facchetti, F; Farina, C; Ferraro, D; Franchin, E; Francisci, D; Galli, S; Garbuglia, Ar; Gennari, W; Ghisetti, V; Lampertico, P; Marascio, N; Menzo, S; Micheli, V; Niro, G; Olivero, A; Paba, P; Palermo, Ci; Palmieri, O; Paolucci, S; Pisaturo, M; Pollicino, T; Raffa, G; Torre, G; Turriziani, O; Uzzau, S; Vatteroni, M; Zazzi, M; Craxì, A; Ceccherini-Silberstein, F; Svicher On Behalf Of The Virology Italian Network Vironet C., V
Heterogeneity in the diagnostic sensitivities of HDV RNA quantification assays used in clinical practice in Italy: data from the first national quality control multicenter study.
2024-01-01 Salpini, 1r; Piermatteo, L; Caviglia, Gp; Bertoli, A; Brunetto, Mr; Bruzzone, B; Callegaro, A; Caudai, C; Cavallone, D; Chessa, L; Coghe, F; Coppola, N; Cuomo, N; D'Anna, S; Di Stefano, M; Duca, L; Facchetti, F; Farina, C; Ferraro, D; Franchin, E; Francisci, D; Galli, S; Garbuglia, Ar; Gennari, W; Ghisetti, V; Lampertico, P; Marascio, N; Menzo, S; Micheli, V; Niro, G; Olivero, A; Paba, P; Palermo, Ci; Palmieri, O; Paolucci, S; Pisaturo, M; Pollicino, T; Raffa, G; Torre, G; Turriziani, O; Uzzau, S; Vatteroni, M; Zazzi, M; Craxì, A; Ceccherini-Silberstein, F; Svicher On Behalf Of The Virology Italian Network Vironet C, V
Higher levels of three HBsAg forms (Large, Middle and Small HBsAg) are associated with HDV replication and with the degree of disease and liver damage.
2023-01-01 Duca, L; Olivero, A; Piermatteo, L; D’Anna, S; Torre, G; Teti, E; DI LORENZO, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; CECCHERINI SILBERSTEIN, F; Milella, M; Saracino, A; Ciancio, A; Sarmati, L; Rizzetto, M; Paolo Caviglia, G; Svicher, V; Salpini, R
HIV/HBV coinfection remodels the immune landscape and natural killer cell ADCC functional responses
2024-09-01 Sun, B; da Costa, Kas; Alrubayyi, A; Kokici, J; Fisher-Pearson, N; Hussain, N; D'Anna, S; Piermatteo, L; Salpini, R; Svicher, V; Kucykowicz, S; Ghosh, I; Burns, F; Kinloch, S; Simoes, P; Bhagani, S; Kennedy, Ptf; Maini, Mk; Bashford-Rogers, R; Gill, Us; Peppa, D
Insights into the Currently Available Drugs and Investigational Compounds Against RSV with a Focus on Their Drug-Resistance Profiles
2025-05-30 Magnapera, A; Riccio, A; Curcio, A; Tramontozzi, C; Piermatteo, L; D'Anna, S; Alcaro, S; Alteri, C; La Frazia, S; Artese, A; Salpini, R; Svicher, V
Kinetics of HBsAg forms in chronic hepatitis delta patients treated with bulevirtide for 48 weeks: correlation with virological response
2023-01-01 D'Anna, S; Salpini, R; Degasperi, E; Duca, L; Anolli, Mp; Piermatteo, L; Sambarino, D; Borghi, M; Facchetti, F; Ceccherini Silberstein, F; Perbellini, R; Lampertico, P; Svicher., V
Kinetics of hepatitis B virus replication in anti-HBc positive/HBsAg-negative people with HIV switching to tenofovir sparing therapy
2025-01-01 Salpini, R; D'Anna, S; Alkhatib, M; Piermatteo, L; Tavelli, A; Benedetti, L; Quiros-Roldan, E; Cingolani, A; Papalini, C; Carrara, S; Malagnino, V; Puoti, M; Sarmati, L; Ceccherini-Silberstein, F; Perno, Cf; Monforte, Ad; Svicher, V
Kinetics of the Three HBsAg Isoforms along with HDV-RNA Predict Virological Response in CHD Patients Treated with Bulevirtide for 48 Weeks
2023-01-01 D'Anna, S; Salpini, R; Degasperi, E; Duca, L; Anolli, Mp; Piermatteo, L; Sambarino, D; Borghi, M; Facchetti, F; Ceccherini-Silberstein, F; Perbellini, R; Lampertico, P; Svicher, V
Long-acting combination of cabotegravir plus rilpivirine: A picture of potential eligible and ineligible HIV-positive individuals from the Italian ARCA cohort
2023-09-01 Cervo, A; Russo, A; Di Carlo, D; De Vito, A; Fabeni, L; D'Anna, S; Duca, L; Colpani, A; Fois, M; Zauli, B; Mancarella, G; Carraro, A; Bezenchek, A; Cozzi-Lepri, A; Santoro, M
PREVALENCE AND OUTCOME OF HEPATITIS DELTA VIRUS (HDV) INFECTION AMONG PERSONS LIVING WITH HIV (PLWH) IN ITALY: THE DELTA-ICONA STUDY OC 150
2023-01-01 Puoti, M; Salpini, R; Tavelli, A; Piermatteo, L; D'Anna, S; Carrara, S; Malagnino, V; Mazzotta, V; Brancaccio, G; Gaeta, Gb; Marchetti, G; Rosselli Del Turco, E; Perno, Cf; Svicher, V; d'Arminio Monforte, A
Prevalence of hepatitis D virus infection in Central Italy has remained stable across the last 2 decades with dominance of subgenotypes 1 and characterized by elevated viral replication
2024-01-01 Salpini, R; Piermatteo, L; Torre, G; D'Anna, S; Khan, S; Duca, L; Bertoli, A; La Frazia, S; Malagnino, V; Teti, E; Iannetta, M; Paba, P; Ciotti, M; Lenci, I; Francioso, S; Paquazzi, C; Lichtner, M; Mastroianni, C; Santopaolo, F; De Sanctis, G; Pellicelli, A; Galati, G; Moretti, A; Casinelli, K; Caterini, L; Iapadre, N; Parruti, G; Vecchiet, I; Paoloni, M; Marignani, M; Ceccherini-Silberstein, F; Baiocchi, L; Grelli, S; Sarmati, L; Svicher, V
SARS-CoV-2 Mutations and Variants May Muddle the Sensitivity of COVID-19 Diagnostic Assays
2022-08-02 Alkhatib, M; Carioti, L; D'Anna, S; Ceccherini-Silberstein, F; Svicher, V; Salpini, R
| Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
|---|---|---|---|---|
| 1-gen-2024 | Chronic HDV infection is sustained by an intense HBsAg production fromintegrated HBVDNA in the setting of a limited or even absent HBV reservoir. | Salpini, 1r; D'Anna, S; Piermatteo, L; Brancaccio, G; Teti, E; Di Lorenzo, A; Grossi, I; Torre, G; Malagnino, V; Iannetta, M; Ceccherini-Silberstein, F; Pasquazzi, C; Cillo, U; Vitale, A; Gringeri, E; Magrofuoco, M; Pacenti, M; Baiocchi, L; Francioso, S; Lenci, I; Koffas, A; Geretti, A; Abate, Ml; Olivero, A; Gaeta, G; Sarmati, L; Rizzetto, M; Gill, U; Kennedy, P; Caviglia, Gp; Svicher., V | Intervento a convegno | |
| 1-gen-2023 | Comprehensive insight of epidemiological and virological features underlying patients with HBV/HDV co-infection drug-naïve or treated with the recently approved entry inhibitor | D'Anna, S | Tesi di dottorato | |
| 1-feb-2024 | Determinants of worse liver-related outcome according to HDV infection among HBsAg positive persons living with HIV: Data from the ICONA cohort | d'Arminio Monforte, A; Tavelli, A; Salpini, R; Piermatteo, L; D'Anna, S; Carrara, S; Malagnino, V; Mazzotta, V; Brancaccio, G; Marchetti, Gc; Rosselli Del Turco, E; Rossotti, R; Mussini, C; Antinori, A; Lo Caputo, S; Ceccherini Silberstein, F; Gaeta, Gb; Svicher, V; Puoti, M | Articolo su rivista | |
| 1-gen-2024 | Different diagnostic performances of HDV RNA quantification assays used in clinical practicein Italy: results from a national quality control multicenter study. | Salpini, 7r; Piermatteo, L; Caviglia, Gp; Bertoli, A; Brunetto, Mr; Bruzzone, B; Callegaro, A; Caudai, C; Cavallone, D; Chessa, L; Coghe, F; Coppola, N; Cuomo, N; D'Anna, S; Di Stefano, M; Duca, L; Facchetti, F; Farina, C; Ferraro, D; Franchin, E; Francisci, D; Galli, S; Garbuglia, Ar; Gennari, W; Ghisetti, V; Lampertico, P; Marascio, N; Menzo, S; Micheli, V; Niro, G; Olivero, A; Paba, P; Palermo, Ci; Palmieri, O; Paolucci, S; Pisaturo, M; Pollicino, T; Raffa, G; Torre, G; Turriziani, O; Uzzau, S; Vatteroni, M; Zazzi, M; Craxì, A; Ceccherini-Silberstein, F; Svicher On Behalf Of The Virology Italian Network Vironet C., V | Intervento a convegno | |
| 1-gen-2023 | Frequency of atypical mutations in the spike glycoprotein in SARS-CoV-2 circulating from July 2020 to July 2022 in central Italy: a refined analysis by Next Generation Sequencing | Bellocchi, Mc; Scutari, R; Carioti, L; Iannetta, M; Marchegiani, G; Piermatteo, L; Coppola, L; Tedde, S; Duca, L; Malagnino, V; Ansaldo, L; Braccialarghe, N; D′Anna, S; Mercedes Santoro, M; DI LORENZO, A; Salpini, R; Teti, E; Svicher, V; Andreoni, M; Sarmati, L; Ceccherini-Silberstein, F | Articolo su rivista | |
| 1-gen-2021 | HBeAg Levels Vary across the Different Stages of HBV Infection According to the Extent of Immunological Pressure and Are Associated with Therapeutic Outcome in the Setting of Immunosuppression-Driven HBV Reactivation | Piermatteo, L; Alkhatib, M; D’Anna, S; Malagnino, V; Bertoli, A; Andreassi, E; Basile, E; Iuvara, A; Maria De Cristofaro, ; Cappiello, G; Cerva, C; Minichini, C; Pisaturo, M; Starace, M; Coppola, N; Fontana, C; Grelli, S; Ceccherini-Silberstein, F; Andreoni, M; Gill, Us; Kennedy, Ptf; Sarmati, L; Salpini, R; Svicher, V | Articolo su rivista | |
| 1-gen-2023 | Hepatitis delta virus (HDV) infection : frequency and outcome in persons living with HIV (PLWH). Data from the ICONA (Italian cohort of naïve for antiretrovirals) cohort | Puoti, M; Salpini, R; Tavelli, A; Piermatteo, L; D’Anna, S; Carrara, S; Malagnino, V; Mazzotta, V; Brancaccio, G; Battista Gaeta, G; Marchetti, G; Viale, P; Perno, C; Svicher, V; d’Arminio Monforte, A | Intervento a convegno | |
| 1-gen-2024 | Heterogeneity in the diagnostic performances of HDV RNA quantification assays used in clinical practice in Italy: results from a national quality control multicenter study. | Salpini, 1r; Piermatteo, L; Caviglia, Gp; Bertoli, A; Brunetto, Mr; Bruzzone, B; Callegaro, A; Caudai, C; Cavallone, D; Chessa, L; Coghe, F; Coppola, N; Cuomo, N; D'Anna, S; Di Stefano, M; Duca, L; Facchetti, F; Farina, C; Ferraro, D; Franchin, E; Francisci, D; Galli, S; Garbuglia, Ar; Gennari, W; Ghisetti, V; Lampertico, P; Marascio, N; Menzo, S; Micheli, V; Niro, G; Olivero, A; Paba, P; Palermo, Ci; Palmieri, O; Paolucci, S; Pisaturo, M; Pollicino, T; Raffa, G; Torre, G; Turriziani, O; Uzzau, S; Vatteroni, M; Zazzi, M; Craxì, A; Ceccherini-Silberstein, F; Svicher On Behalf Of The Virology Italian Network Vironet C., V | Intervento a convegno | |
| 1-gen-2024 | Heterogeneity in the diagnostic sensitivities of HDV RNA quantification assays used in clinical practice in Italy: data from the first national quality control multicenter study. | Salpini, 1r; Piermatteo, L; Caviglia, Gp; Bertoli, A; Brunetto, Mr; Bruzzone, B; Callegaro, A; Caudai, C; Cavallone, D; Chessa, L; Coghe, F; Coppola, N; Cuomo, N; D'Anna, S; Di Stefano, M; Duca, L; Facchetti, F; Farina, C; Ferraro, D; Franchin, E; Francisci, D; Galli, S; Garbuglia, Ar; Gennari, W; Ghisetti, V; Lampertico, P; Marascio, N; Menzo, S; Micheli, V; Niro, G; Olivero, A; Paba, P; Palermo, Ci; Palmieri, O; Paolucci, S; Pisaturo, M; Pollicino, T; Raffa, G; Torre, G; Turriziani, O; Uzzau, S; Vatteroni, M; Zazzi, M; Craxì, A; Ceccherini-Silberstein, F; Svicher On Behalf Of The Virology Italian Network Vironet C, V | Intervento a convegno | |
| 1-gen-2023 | Higher levels of three HBsAg forms (Large, Middle and Small HBsAg) are associated with HDV replication and with the degree of disease and liver damage. | Duca, L; Olivero, A; Piermatteo, L; D’Anna, S; Torre, G; Teti, E; DI LORENZO, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; CECCHERINI SILBERSTEIN, F; Milella, M; Saracino, A; Ciancio, A; Sarmati, L; Rizzetto, M; Paolo Caviglia, G; Svicher, V; Salpini, R | Intervento a convegno | |
| 1-set-2024 | HIV/HBV coinfection remodels the immune landscape and natural killer cell ADCC functional responses | Sun, B; da Costa, Kas; Alrubayyi, A; Kokici, J; Fisher-Pearson, N; Hussain, N; D'Anna, S; Piermatteo, L; Salpini, R; Svicher, V; Kucykowicz, S; Ghosh, I; Burns, F; Kinloch, S; Simoes, P; Bhagani, S; Kennedy, Ptf; Maini, Mk; Bashford-Rogers, R; Gill, Us; Peppa, D | Articolo su rivista | |
| 30-mag-2025 | Insights into the Currently Available Drugs and Investigational Compounds Against RSV with a Focus on Their Drug-Resistance Profiles | Magnapera, A; Riccio, A; Curcio, A; Tramontozzi, C; Piermatteo, L; D'Anna, S; Alcaro, S; Alteri, C; La Frazia, S; Artese, A; Salpini, R; Svicher, V | Articolo su rivista | |
| 1-gen-2023 | Kinetics of HBsAg forms in chronic hepatitis delta patients treated with bulevirtide for 48 weeks: correlation with virological response | D'Anna, S; Salpini, R; Degasperi, E; Duca, L; Anolli, Mp; Piermatteo, L; Sambarino, D; Borghi, M; Facchetti, F; Ceccherini Silberstein, F; Perbellini, R; Lampertico, P; Svicher., V | Intervento a convegno | |
| 1-gen-2025 | Kinetics of hepatitis B virus replication in anti-HBc positive/HBsAg-negative people with HIV switching to tenofovir sparing therapy | Salpini, R; D'Anna, S; Alkhatib, M; Piermatteo, L; Tavelli, A; Benedetti, L; Quiros-Roldan, E; Cingolani, A; Papalini, C; Carrara, S; Malagnino, V; Puoti, M; Sarmati, L; Ceccherini-Silberstein, F; Perno, Cf; Monforte, Ad; Svicher, V | Articolo su rivista | |
| 1-gen-2023 | Kinetics of the Three HBsAg Isoforms along with HDV-RNA Predict Virological Response in CHD Patients Treated with Bulevirtide for 48 Weeks | D'Anna, S; Salpini, R; Degasperi, E; Duca, L; Anolli, Mp; Piermatteo, L; Sambarino, D; Borghi, M; Facchetti, F; Ceccherini-Silberstein, F; Perbellini, R; Lampertico, P; Svicher, V | Intervento a convegno | |
| 1-set-2023 | Long-acting combination of cabotegravir plus rilpivirine: A picture of potential eligible and ineligible HIV-positive individuals from the Italian ARCA cohort | Cervo, A; Russo, A; Di Carlo, D; De Vito, A; Fabeni, L; D'Anna, S; Duca, L; Colpani, A; Fois, M; Zauli, B; Mancarella, G; Carraro, A; Bezenchek, A; Cozzi-Lepri, A; Santoro, M | Articolo su rivista | |
| 1-gen-2023 | PREVALENCE AND OUTCOME OF HEPATITIS DELTA VIRUS (HDV) INFECTION AMONG PERSONS LIVING WITH HIV (PLWH) IN ITALY: THE DELTA-ICONA STUDY OC 150 | Puoti, M; Salpini, R; Tavelli, A; Piermatteo, L; D'Anna, S; Carrara, S; Malagnino, V; Mazzotta, V; Brancaccio, G; Gaeta, Gb; Marchetti, G; Rosselli Del Turco, E; Perno, Cf; Svicher, V; d'Arminio Monforte, A | Intervento a convegno | |
| 1-gen-2024 | Prevalence of hepatitis D virus infection in Central Italy has remained stable across the last 2 decades with dominance of subgenotypes 1 and characterized by elevated viral replication | Salpini, R; Piermatteo, L; Torre, G; D'Anna, S; Khan, S; Duca, L; Bertoli, A; La Frazia, S; Malagnino, V; Teti, E; Iannetta, M; Paba, P; Ciotti, M; Lenci, I; Francioso, S; Paquazzi, C; Lichtner, M; Mastroianni, C; Santopaolo, F; De Sanctis, G; Pellicelli, A; Galati, G; Moretti, A; Casinelli, K; Caterini, L; Iapadre, N; Parruti, G; Vecchiet, I; Paoloni, M; Marignani, M; Ceccherini-Silberstein, F; Baiocchi, L; Grelli, S; Sarmati, L; Svicher, V | Articolo su rivista | |
| 2-ago-2022 | SARS-CoV-2 Mutations and Variants May Muddle the Sensitivity of COVID-19 Diagnostic Assays | Alkhatib, M; Carioti, L; D'Anna, S; Ceccherini-Silberstein, F; Svicher, V; Salpini, R | Articolo su rivista |